Surgical Oncology Program
Information for Patients
Learn more about our clinical trials and the highly specialized care teams who lead them.
Surgical Oncology Program
About
About Our Program
Our clinical trials focus on gastrointestinal cancers (stomach, small bowel, colon/rectum, liver, pancreas and bile duct) as well as endocrine cancers (thyroid, parathyroid, adrenal, gastrointestinal tract and pancreas) and a myriad of endocrine tumor syndromes. Expertise in both diagnosis and treatment is necessary to provide patients with the best possible outcomes. Patients require experts in the fields of surgical oncology, gastroenterology, endocrinology, medical oncology, radiation therapy, interventional radiology and more. Members of our surgical team have partnered together, providing patient care for over ten years. It is our seamless and integrated approach to cancer treatment as well as cutting edge clinical protocols and research that is the greatest benefit to our patients.
Clinical Trials
Job Vacancies
Position | Degree Required | Contact Name | Contact Email |
---|---|---|---|
Clinical Fellow - Surgical Oncology, Fellowship, Training | M.D. or equivalent | Joanna Lamot | joanna.lamot@nih.gov |
Postdoctoral Fellow - Neuro-endocrine cancer, Bioinformatics, Functional genomics | Ph.D. or equivalent | Anna Coxen | anna.coxen@nih.gov |
News
Science
Our Research Interests
- Dr. Clint Allen is an Otolaryngologist whose basic and clinical research focuses on understanding dysfunctional immune responses within human papillomavirus positive and negative head and neck cancers as well as recurrent respiratory papillomatosis and how anti-tumor immunity can be therapeutically enhanced to improve clinical outcomes for patients with these disorders
- Dr. Andrew Blakely is a surgical oncologist specializing in peritoneal surface and retroperitoneal malignancies. A primary focus of his research is to develop novel treatment approaches and modalities to improve pre-operative treatment of peritoneal carcinomatosis.
- Dr. Jeremy Davis is a surgical oncologist whose research focuses on sporadic and inherited forms of stomach cancer, specifically those caused by germline mutations in the CDH1 gene. Dr. Davis is recognized both nationally and internationally as an expert in CDH1 and the Hereditary Diffuse Gastric Cancer syndrome. His research is focused on understanding the molecular underpinnings of gastric cancer development and metastasis. Dr. Davis is board certified in both Complex General Surgical Oncology and General Surgery.
- Dr. Jonathan Hernandez is a surgical oncologist and hepatopancreatobiliary surgeon whose research efforts focus on elucidating the mechanisms through which tumor cells coopt the microenvironment of distant organs to form life-threatening metastases in order to interrupt this process prior to its completion.
- Dr. Nyall London is an otolaryngology surgeon-scientist specialized in open and endoscopic resection of sinonasal and skull base malignancies. His research laboratory utilizes a variety of in vitro and in vivo approaches to identify critical genes that drive sinonasal tumor development, determine their mechanism of action, and assess their potential as therapeutic targets. We are actively developing a series of clinical trials to improve treatment effectiveness and survival in patients with sinonasal and skull base cancers.
- Dr. Naris Nilubol is a surgeon-scientist specialized in endocrine oncology surgery and clinical research involving thyroid, parathyroid, adrenal, and neuroendocrine tumors. His laboratory research focus includes the identification of novel targeted therapeutics in endocrine cancers and novel cancer drug delivery methods by targeting tumor microenvironment.
- Dr. Samira Sadowski specializes in endocrine surgery and her research focuses on the identification of diagnostic and prognostic markers for endocrine tumors and developing new therapies for such tumors.
- Dr. Martha Zeiger is an internationally renowned endocrine surgeon and scientist who has been a leader in developing molecular diagnostics for thyroid cancer. Dr. Zeiger directs the CCR Office of Surgeon-Scientist Career Development, Office of the Clinical Director, where she leads a team studying and designing future pathways for the professional development of surgeon-scientists. Her research interests focus on TERT gene expression regulation, molecular marker diagnostic panel development and molecular biological aspects of thyroid cancer development.
Training
![Surgical Oncology Program Trainees](/sites/default/files/styles/quarter_1_1/public/LBP_Training_Tab/SOP_Trainees.png?itok=LiagUG-7)
Training Opportunities
Clinical
Research
Events
Genotype-Phenotype Associations and Lifetime Risks in Hereditary Diffuse Gastric Cancer and Lobular Breast Cancer Syndrome
Hereditary Cancer Series hosted by NCI CCR Surgical Oncology Program
Date: Wednesday, November 1, 2023, 2:00-3:00pm ET
Location: Hybrid, FAES Rooms 3 & 4
WebEx
Meeting number: 2311 781 1554
Password: SqTmRFT6*22
Join by video system. Dial 23117811554@cbiit.webex.com
You can also dial 173.243.2.68 and enter your meeting number.
Join by phone: 1-650-479-3207 Call-in toll number (US/Canada)
Access code: 231 178 11554
For more information, please contact Joanna.Lamot@nih.gov or 240-858-3731.
Carla Oliveira, Ph.D., Principal Investigator, University of Porto, Portugal
Dr. Oliveira is recognized internationally for her work in E-cadherin/CDH1-related diseases and hereditary cancer. She has disclosed novel germline causes and genotype-phenotype associations in hereditary gastrointestinal cancer and defined somatic events in tumors with impacts on patient management and therapy. Her research focus is on discovery of genomic causes of hereditary gastric cancer, actionable genotype-phenotype relationships, biomarker discovery for early cancer detection using stomach-on-a-chip and iPSCs and assessing the social and economic impact of hereditary cancer by interacting with patient groups.
Dr. Oliveira’s group has relevant roles in management and executive functions in the GenomePT National Infrastructure for genome sequencing and the 1 Million European Genomes project. Her team was recently awarded with the Prize Alfredo da Silva on “Sustainability of Health Systems” for the work on optimized pathways of care in Hereditary cancer syndromes.